Invitation to give a lecture in prestigious post-graduate course

The Institute of Pharmaceutical Medicine at the University of Basel invited Bryan Bennett from Adelphi Values to give a lecture to students of the post-graduate ‘European Course of Pharmaceutical Medicine’, a course which is typically undertaken by pharmaceutical industry professionals.

The lecture titled ‘Epidemiology and patient-reported outcome studies’ was part of the seminar ‘Continuing Education Series – Frontiers in Drug Development: Key Concepts in Clinical Trial Design’ and covered the value of using Patient-Reported Outcomes (PROs) throughout the drug development process. More specifically, the use of PROs in clinical trials, the regulatory considerations, the development of PROs, industry good practice standards and the application of PROs and stakeholder value were discussed

As a leading expert in patient-reported outcomes, Bryan delivered the lecture and said “I felt very privileged to have been asked to participate in the lecture series. The ECPM is a centre of excellence in pharmaceutical training and development so it was great to be part of the seminar and share my knowledge in this way.”  Excellent feedback followed the completion of this lecture with students stating that it was “very clear and informative – extremely helpful”, that they enjoyed the presentation and learnt a lot from it.

The European Center of Pharmaceutical Medicine (ECPM) is a leading university institute for medicine and drug development in Europe, with over 1600 experts having successfully completed their postgraduate training courses over the last 22 years.

If you would like further information on this lecture, our available training workshops or on any of our broader patient-centered research solutions, please contact us or alternatively email us at info@adelphivalues.com